-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $93

Benzinga·11/10/2025 20:39:58
Listen to the news
Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and lowers the price target from $101 to $93.